These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2023921)

  • 1. c-rel activates but v-rel suppresses transcription from kappa B sites.
    Inoue J; Kerr LD; Ransone LJ; Bengal E; Hunter T; Verma IM
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3715-9. PubMed ID: 2023921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Grilli M; Chiu JJ; Lenardo MJ
    Int Rev Cytol; 1993; 143():1-62. PubMed ID: 8449662
    [No Abstract]   [Full Text] [Related]  

  • 3. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    Ballard DW; Dixon EP; Peffer NJ; Bogerd H; Doerre S; Stein B; Greene WC
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1875-9. PubMed ID: 1542686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rel/NF-kappa B/I kappa B story.
    Miyamoto S; Verma IM
    Adv Cancer Res; 1995; 66():255-92. PubMed ID: 7793317
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J; Brent R
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.
    Ishikawa H; Asano M; Kanda T; Kumar S; Gélinas C; Ito Y
    Oncogene; 1993 Nov; 8(11):2889-96. PubMed ID: 8414493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element.
    Sica A; Tan TH; Rice N; Kretzschmar M; Ghosh P; Young HA
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1740-4. PubMed ID: 1542667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
    La Rosa FA; Pierce JW; Sonenshein GE
    Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
    Diehl JA; McKinsey TA; Hannink M
    Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-rel- and c-rel-protein complexes bind to the NF-kappa B site in vitro.
    Kochel T; Rice NR
    Oncogene; 1992 Mar; 7(3):567-72. PubMed ID: 1549370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Ballard DW; Walker WH; Doerre S; Sista P; Molitor JA; Dixon EP; Peffer NJ; Hannink M; Greene WC
    Cell; 1990 Nov; 63(4):803-14. PubMed ID: 2225078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEST-dependent cytoplasmic retention of v-Rel by I(kappa)B-alpha: evidence that I(kappa)B-alpha regulates cellular localization of c-Rel and v-Rel by distinct mechanisms.
    Rottjakob EM; Sachdev S; Leanna CA; McKinsey TA; Hannink M
    J Virol; 1996 May; 70(5):3176-88. PubMed ID: 8627798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
    Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.
    Perkins ND; Schmid RM; Duckett CS; Leung K; Rice NR; Nabel GJ
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1529-33. PubMed ID: 1542644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
    Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.